Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marion Thibaudin

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Annales De Pathologie|February 5, 2017
[The anti-tumor immune response in breast cancer: Update and therapeutic perspectives]Sylvain Ladoire, Valentin Derangère, Laurent Arnould, et al.
Cancer Immunology, Immunotherapy : CII|May 16, 2024
Effect of radiochemotherapy on peripheral immune response in glioblastomaLéa Hampe, Susy Daumoine, Emeric Limagne, et al.
Cancer Immunology Research|October 16, 2019
Trifluridine/Tipiracil plus Oxaliplatin Improves PD-1 Blockade in Colorectal Cancer by Inducing Immunogenic Cell Death and Depleting MacrophagesEmeric Limagne, Marion Thibaudin, Lisa Nuttin, et al.
Oncoimmunology|June 20, 2026
Pooled analysis of 2 clinical trials of first-line chemoimmunotherapy for metastatic microsatellite stable colorectal cancer MEDITREME and METIMMOX studiesCaroline Truntzer, Marion Thibaudin, Paula Anna Bousquet, et al.
Cancer Research|November 6, 2025
Tumor-Associated Macrophages Produce PGE2 to Promote CD8+ T Cell Exhaustion and Drive Resistance to PD-L1 Blockade in Microsatellite Stable Colorectal CancerJean-David Fumet, Charlène Latour, Lisa Nuttin, et al.
Journal for Immunotherapy of Cancer|June 27, 2019
Optimized fractionated radiotherapy with anti-PD-L1 and anti-TIGIT: a promising new combinationMathieu Grapin, Corentin Richard, Emeric Limagne, et al.
Nature Communications|January 24, 2018
Lysophosphatidylcholine acyltransferase 2-mediated lipid droplet production supports colorectal cancer chemoresistanceAlexia Karen Cotte, Virginie Aires, Maxime Fredon, et al.
Cell Reports|April 27, 2017
Sirtuin-1 Activation Controls Tumor Growth by Impeding Th17 Differentiation via STAT3 DeacetylationEmeric Limagne, Marion Thibaudin, Romain Euvrard, et al.
Nature Communications|December 14, 2017
IRF8-dependent molecular complexes control the Th9 transcriptional programEtienne Humblin, Marion Thibaudin, Fanny Chalmin, et al.
Cancer Research|August 7, 2016
Accumulation of MDSC and Th17 Cells in Patients with Metastatic Colorectal Cancer Predicts the Efficacy of a FOLFOX-Bevacizumab Drug Treatment RegimenEmeric Limagne, Romain Euvrard, Marion Thibaudin, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Annales De Pathologie|February 5, 2017
[The anti-tumor immune response in breast cancer: Update and therapeutic perspectives]Sylvain Ladoire, Valentin Derangère, Laurent Arnould, et al.
Cancer Immunology, Immunotherapy : CII|May 16, 2024
Effect of radiochemotherapy on peripheral immune response in glioblastomaLéa Hampe, Susy Daumoine, Emeric Limagne, et al.
Cancer Immunology Research|October 16, 2019
Trifluridine/Tipiracil plus Oxaliplatin Improves PD-1 Blockade in Colorectal Cancer by Inducing Immunogenic Cell Death and Depleting MacrophagesEmeric Limagne, Marion Thibaudin, Lisa Nuttin, et al.
Oncoimmunology|June 20, 2026
Pooled analysis of 2 clinical trials of first-line chemoimmunotherapy for metastatic microsatellite stable colorectal cancer MEDITREME and METIMMOX studiesCaroline Truntzer, Marion Thibaudin, Paula Anna Bousquet, et al.
Cancer Research|November 6, 2025
Tumor-Associated Macrophages Produce PGE2 to Promote CD8+ T Cell Exhaustion and Drive Resistance to PD-L1 Blockade in Microsatellite Stable Colorectal CancerJean-David Fumet, Charlène Latour, Lisa Nuttin, et al.
Journal for Immunotherapy of Cancer|June 27, 2019
Optimized fractionated radiotherapy with anti-PD-L1 and anti-TIGIT: a promising new combinationMathieu Grapin, Corentin Richard, Emeric Limagne, et al.
Nature Communications|January 24, 2018
Lysophosphatidylcholine acyltransferase 2-mediated lipid droplet production supports colorectal cancer chemoresistanceAlexia Karen Cotte, Virginie Aires, Maxime Fredon, et al.
Cell Reports|April 27, 2017
Sirtuin-1 Activation Controls Tumor Growth by Impeding Th17 Differentiation via STAT3 DeacetylationEmeric Limagne, Marion Thibaudin, Romain Euvrard, et al.
Nature Communications|December 14, 2017
IRF8-dependent molecular complexes control the Th9 transcriptional programEtienne Humblin, Marion Thibaudin, Fanny Chalmin, et al.
Cancer Research|August 7, 2016
Accumulation of MDSC and Th17 Cells in Patients with Metastatic Colorectal Cancer Predicts the Efficacy of a FOLFOX-Bevacizumab Drug Treatment RegimenEmeric Limagne, Romain Euvrard, Marion Thibaudin, et al.
Pageof 4